NYSE:SQZ
SQZ Biotechnologies Company
- Stock
Last Close
0.27
03/07 17:00
Market Cap
12.83M
Beta: 2.69
Volume Today
30.14M
Avg: 326.38K
PE Ratio
−0.42
PFCF: −0.15
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|
average inventory | -192K - | |||||
average payables | 1.94M - | 3.25M 67.50% | 3.84M 18.07% | 3.24M 15.59% | ||
average receivables | 1.67M - | 2.26M 35.67% | 2.77M 22.34% | 1.74M 37.17% | ||
book value per share | -3.02 - | -4.10 35.81% | 23.55 673.91% | 4.50 80.91% | 1.98 55.88% | |
capex per share | 2.72 - | -0.12 104.44% | -0.22 80.07% | -0.02 89.80% | -0.02 18.49% | |
capex to depreciation | 36.79 - | -0.50 101.35% | -0.11 78.39% | -0.06 48.33% | -0.04 19.61% | |
capex to operating cash flow | 1.86 - | 0.06 96.52% | 0.03 57.86% | 0.01 72.64% | 0.01 16.28% | |
capex to revenue | 3.10 - | -0.11 103.62% | -0.06 50.05% | -0.02 59.64% | -0.02 9.73% | |
cash per share | 7.42 - | 5.49 26.06% | 31.54 474.94% | 5.20 83.50% | 2.21 57.51% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | 36.07 - | 39.38 9.16% | 42.45 7.80% | 41.69 1.79% | 6.67 84.01% | |
debt to assets | 0.28 - | 0.20 26.67% | 0.31 51.25% | 0.27 10.77% | ||
debt to equity | -0.58 - | 0.37 164.30% | 0.56 51.83% | 0.48 14.49% | ||
dividend yield | ||||||
earnings yield | -0.10 - | -0.13 25.94% | -0.32 151.51% | -0.28 12.62% | -3.67 1,215.29% | |
enterprise value | 131.39M - | 240.48M 83.03% | 33.28M 86.16% | 172.46M 418.13% | -14.92M 108.65% | |
enterprise value over ebitda | -7.25 - | -8.64 19.13% | -0.83 90.39% | -2.99 259.98% | 0.25 108.42% | |
ev to operating cash flow | 6.23 - | -7.18 215.30% | -0.77 89.26% | -2.10 172.20% | 0.18 108.50% | |
ev to sales | 10.37 - | 12.45 20.03% | 1.59 87.27% | 6.36 301.49% | -0.71 111.15% | |
free cash flow per share | 1.37 - | -1.99 244.92% | -8.21 312.33% | -3.00 63.44% | -2.92 2.76% | |
free cash flow yield | 0.10 - | -0.15 244.92% | -0.28 88.52% | -0.34 18.66% | -3.94 1,073.51% | |
graham net net | -3.55 - | -7.03 97.84% | 12.63 279.63% | 1.58 87.47% | 0.73 53.84% | |
graham number | 9.53 - | 12.46 30.78% | 70.02 461.87% | 15.87 77.33% | 11.01 30.65% | |
income quality | -1.10 - | 1.04 194.90% | 0.85 17.88% | 1.19 39.90% | 1.05 12.01% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -345.83 - | -8.30 - | ||||
interest debt per share | 0.00 - | 2.36 57,610.61% | 8.72 269.02% | 2.53 71.01% | 1.29 48.92% | |
inventory turnover | ||||||
invested capital | -0.58 - | 0.37 164.30% | 0.56 51.83% | 0.48 14.49% | ||
market cap | 190.96M - | 237.41M 24.32% | 156.55M 34.06% | 246.28M 57.32% | 21.32M 91.34% | |
net current asset value | -50.27M - | -124.05M 146.74% | 72.89M 158.76% | 48.46M 33.52% | 25.45M 47.48% | |
net debt to ebitda | 3.29 - | -0.11 103.36% | 3.07 2,881.63% | 1.28 58.39% | 0.61 52.19% | |
net income per share | -1.34 - | -1.68 25.94% | -9.25 450.09% | -2.49 73.07% | -2.72 8.99% | |
operating cash flow per share | 1.46 - | -1.87 227.69% | -7.99 327.36% | -2.98 62.72% | -2.90 2.64% | |
payables turnover | ||||||
receivables turnover | 10.12 - | 9.27 8.39% | 8.60 7.24% | 8.76 1.82% | 54.76 525.48% | |
research and ddevelopement to revenue | 1.92 - | 1.87 2.88% | 2.45 31.35% | 2.59 5.46% | 3.38 30.40% | |
return on tangible assets | -0.17 - | -0.20 18.74% | -0.22 9.31% | -0.30 40.50% | -0.78 157.78% | |
revenue per share | 0.88 - | 1.08 22.65% | 3.89 260.54% | 0.98 74.72% | 0.73 25.72% | |
roe | 0.44 - | 0.41 7.27% | -0.39 195.85% | -0.55 41.04% | -1.37 147.03% | |
roic | 0.47 - | -2.88 713.92% | -0.23 92.07% | -0.26 14.39% | -0.71 171.54% | |
sales general and administrative to revenue | 0.69 - | 0.95 37.83% | 0.98 3.27% | 0.95 2.84% | 1.25 31.87% | |
shareholders equity per share | -3.02 - | -4.10 35.81% | 23.55 673.91% | 4.50 80.91% | 1.98 55.88% | |
stock based compensation to revenue | 0.05 - | 0.11 134.31% | 0.17 57.20% | 0.31 82.97% | 0.40 27.31% | |
tangible asset value | -43.54M - | -73.52M 68.84% | 127.20M 273.02% | 123.98M 2.53% | 57.15M 53.90% | |
tangible book value per share | -3.02 - | -4.10 35.81% | 23.55 673.91% | 4.50 80.91% | 1.98 55.88% | |
working capital | 87.48M - | 63.53M 27.37% | 131.64M 107.19% | 117.41M 10.81% | 46.36M 60.51% |
All numbers in USD (except ratios and percentages)